Intervention

GW856553

ClinicalTrials.gov intervention label

Clinical trials6

Recruiting0

Common conditions6

Lead sponsors shown1

Clinical trials

6 shown

Clinical Study to Test a New Drug to Treat Major DepressionNCT00976560 · 2009-09-25

A 12 Week Study To Assess Efficacy And Safety Of GW856553 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT00642148 · 2008-02-14

A Study to Examine the Effect of Particle Size on Bioequivalence and BioavailabilityNCT00517543 · 2007-08-01

A Study To Investigate The Effect Of 28 Days Of Dosing With GW856553 On Patients With Rheumatoid ArthritisNCT00393146 · 2006-10-01

A Study To Investigate The Effects Of GW856553 On Patients With COPD (Chronic Obstructive Pulmonary Disease)NCT00392587 · 2006-08-01

Single Dose Study Of GW856553 On A Protein That Is An Indicator For Rheumatoid Arthritis (RA)NCT00256919 · 2005-11-01

Common conditions

Arthritis, Rheumatoid2 Chronic Obstructive Pulmonary Disease (COPD)2 Pulmonary Disease, Chronic Obstructive2 Atherosclerosis1 Depressive Disorder, Major1 Rheumatoid Arthritis1

Leading sponsors

GlaxoSmithKline6

Trial status mix

COMPLETED6

Phase mix

PHASE25

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.